Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
toxicology
Biotech
Incyte's $750M buyout rocked by pause on key trial, asset cull
Less than six months after closing the deal, Incyte has paused a key study over preclinical toxicology findings and axed another program altogether.
Nick Paul Taylor
Nov 19, 2024 4:12am
Danish CRO Scantox buys genotoxicity specialist Gentronix
Sep 10, 2024 7:44am
Scientists find largest protein ever in tiny toxic algae
Aug 12, 2024 12:02pm
AstraZeneca stops trials of asthma drug after seeing tox signal
Jun 21, 2023 9:10am
AbbVie drops midphase psoriasis drug over toxicology data
Oct 31, 2022 7:40am
Inotiv nabs MilliporeSigma BioReliance portfolio
Jul 13, 2021 7:55am
